What Is Selank? Tuftsin-Derived Anxiolytic Peptide and GABA Modulation

Selank is a synthetic heptapeptide that has become one of the more closely studied research compounds in the literature on stress, anxiety, and neuroimmune signaling. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences together with the Zakusov Institute of Pharmacology, it is structurally derived from tuftsin, a short peptide the body produces naturally. In preclinical and laboratory research, Selank has been investigated as an anxiolytic that appears to act through GABAergic, serotonergic, and enkephalin-related pathways rather than the classic sedative mechanism of benzodiazepines. This article explains what Selank is, where it comes from, and what the research literature actually supports. Everything below is framed strictly for laboratory and preclinical context: Selank sold by SoCal Labs 1776 is research use only and not for human consumption.

Selank and Its Tuftsin Origin

Selank is a synthetic analog of the endogenous tetrapeptide tuftsin. Tuftsin (Thr-Lys-Pro-Arg) is a naturally occurring fragment derived from the heavy chain of immunoglobulin G (IgG), where it has long been characterized as an immunomodulatory signaling peptide. The problem researchers faced with tuftsin itself is that it is degraded very rapidly in biological systems, which makes it difficult to study its activity over any meaningful timescale.

To address that instability, chemists extended the tuftsin sequence with a C-terminal Pro-Gly-Pro tripeptide. The result is Selank, a more metabolically stable molecule that retains tuftsin-associated activity while resisting the rapid enzymatic breakdown that limits the parent peptide. This is the same stabilization strategy used to create Selank's better-known counterpart, Semax, which is discussed below.

Structure: A Tuftsin Heptapeptide Analog

Selank is a heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Reading that sequence makes its lineage obvious: the first four residues (Thr-Lys-Pro-Arg) are tuftsin itself, and the final three (Pro-Gly-Pro) are the synthetic stabilizing extension.

• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (tuftsin + Pro-Gly-Pro)
• Class: synthetic heptapeptide / tuftsin analog
• Molecular formula: C33H57N11O9
• Approx. molecular weight: ~751.9 Da
• Design rationale: improved metabolic stability versus native tuftsin

The proline-rich C-terminus is the key structural feature. Proline residues sterically hinder many peptidases, so the Pro-Gly-Pro motif slows degradation and gives Selank a longer functional window in experimental preparations than the rapidly cleaved tuftsin fragment. For lot-specific identity and purity data on the material itself, see the Certificate of Analysis verification page.

Mechanism: GABA and Serotonin Modulation

Across preclinical work, Selank is described as a peptide that modulates GABAergic and serotonergic neurotransmission rather than binding a single classical receptor like a small-molecule drug. The picture that emerges from the literature is one of broad neuromodulation.

GABAergic effects

GABA is the brain's primary inhibitory neurotransmitter, and inhibitory tone is central to how anxiolytic compounds are studied. Gene-expression research in rodents has reported that Selank administration alters the expression of several genes involved in GABAergic neurotransmission, which is consistent with its observed anxiolytic-like behavior in animal stress models. Importantly, the literature emphasizes that Selank's GABA-related activity appears distinct from the benzodiazepine binding site, which is one proposed reason it has been studied as an anxiolytic that does not produce the heavy sedation typical of that drug class.

Serotonergic effects

Selank has also been investigated for its effects on serotonin (5-HT) metabolism. In rodent studies using p-chlorophenylalanine (PCPA, a serotonin-synthesis inhibitor), Selank was reported to enhance 5-HT metabolism in the brainstem, an effect not produced by tuftsin under the same conditions. Other rodent work links Selank's anxiolytic-like activity to region-specific changes in serotonin levels across structures such as the frontal cortex, hypothalamus, and amygdala. These are animal-model findings; they describe neurochemistry in rodents, not validated effects in humans.

Enkephalin and Stress-System Effects

One of the most distinctive and best-documented mechanistic findings for Selank involves the enkephalin system. Enkephalins are endogenous opioid peptides involved in pain modulation, mood, and stress regulation, and they are normally broken down quickly by enkephalin-degrading enzymes (enkephalinases).

A frequently cited preclinical study (Zozulya and colleagues, published in 2001 and indexed on PubMed) reported that Selank dose-dependently inhibits the enzymatic hydrolysis of enkephalins in plasma, and did so more potently than reference peptidase inhibitors such as bacitracin and puromycin. By slowing enkephalin breakdown, Selank could effectively prolong endogenous enkephalin signaling. Researchers have proposed this enkephalin-stabilizing effect as a possible contributor to its anxiolytic activity in animal models, tying together its stress-system and mood-related observations.

Across these pathways, a consistent theme in the literature is that Selank is studied as an anxiolytic without the classic sedative profile — animal data and early clinical reports describe anxiety-attenuating activity alongside reported anti-asthenic (anti-fatigue) and mild psychostimulant-like effects, in contrast to the drowsiness associated with benzodiazepines. These remain research observations; SoCal Labs 1776 makes no therapeutic or human-use claims.

Selank vs Semax at a Glance

Selank is often discussed alongside Semax because both are proline-stabilized peptide analogs from the same Russian research programs and both are studied for effects on the central nervous system. But they originate from different parent peptides and are investigated for different primary endpoints.

• Parent peptide: Selank derives from tuftsin (an immune-derived tetrapeptide); Semax derives from a fragment of ACTH(4-10).
• Primary research focus: Selank is studied mainly for calm / anxiolytic endpoints; Semax is studied mainly for focus, cognition, and BDNF upregulation.
• Signature mechanisms: Selank — GABAergic modulation, serotonin regulation, enkephalinase inhibition. Semax — melanocortin signaling, BDNF, dopaminergic/serotonergic tone.
• Shared design trait: both use a Pro-Gly-Pro extension for metabolic stability.

In short, the two peptides are complementary in the research literature: Selank targets calm and anxiolytic-type effects, while Semax targets focus and neurotrophic (BDNF) endpoints. Some labs study them in parallel, which is why you'll see both in our product catalog.

Lab Handling and Reconstitution

Selank is typically supplied as a lyophilized (freeze-dried) powder for laboratory use. The notes below describe general handling practices for research material and are not administration instructions for any living subject.

• Storage (lyophilized): keep sealed and protected from light; long-term storage is generally at -20C. Short transit at ambient temperature is usually tolerated for stable lyophilized peptides.
• Reconstitution solvent: bacteriostatic or sterile water is commonly used to dissolve lyophilized peptides for in-vitro work; add solvent slowly down the vial wall rather than directly onto the powder.
• Mixing: swirl gently and allow the powder to dissolve — avoid vigorous shaking, which can shear and denature peptides.
• Reconstituted storage: keep refrigerated (2-8C) and use within the window indicated on the lot documentation; avoid repeated freeze-thaw cycles.
• Documentation: record lot number and reconstitution date, and cross-reference the Certificate of Analysis for that lot.

Because peptides vary in solubility and stability, always work from the lot-specific COA and your own facility's protocols. Every Selank lot from SoCal Labs 1776 is third-party HPLC tested and lot-tracked so identity and purity can be independently confirmed.

Research Use Only

Selank is a synthetic, tuftsin-derived heptapeptide studied in preclinical and laboratory settings for its anxiolytic-like, GABA-modulating, serotonergic, and enkephalin-stabilizing properties. Much of the supporting evidence comes from rodent models and early clinical reports, and human evidence remains limited; claims about effects in people should not be inferred from animal data.

To review current inventory and lot documentation, see the Selank product page and verify any lot on our COA portal. For a related comparison, read our overview of Semax.